That assuming that even this idea was intended to be implemented
An excuse to sell every A/S and raise it again. At which point shareholders will get the failure excuse "we couldn't make it work because of the FDA, blah, blah and blah." In the meantime, no accounting for where the "development" cash went ... wash, rinse and repeat.